These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 25918406)

  • 21. CRISPR-Cas-mediated targeted genome editing in human cells.
    Yang L; Mali P; Kim-Kiselak C; Church G
    Methods Mol Biol; 2014; 1114():245-67. PubMed ID: 24557908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First indication for a functional CRISPR/Cas system in Francisella tularensis.
    Schunder E; Rydzewski K; Grunow R; Heuner K
    Int J Med Microbiol; 2013 Mar; 303(2):51-60. PubMed ID: 23333731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.
    Anderson EM; Haupt A; Schiel JA; Chou E; Machado HB; Strezoska Ž; Lenger S; McClelland S; Birmingham A; Vermeulen A; Smith Av
    J Biotechnol; 2015 Oct; 211():56-65. PubMed ID: 26189696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depletion of elongation initiation factor 4E binding proteins by CRISPR/Cas9 enhances the antiviral response in porcine cells.
    Ramírez-Carvajal L; Singh N; de los Santos T; Rodríguez LL; Long CR
    Antiviral Res; 2016 Jan; 125():8-13. PubMed ID: 26592975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing RNA virus resistance in plants by harnessing CRISPR immune system.
    Zhang T; Zheng Q; Yi X; An H; Zhao Y; Ma S; Zhou G
    Plant Biotechnol J; 2018 Aug; 16(8):1415-1423. PubMed ID: 29327438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells.
    Liao HK; Gu Y; Diaz A; Marlett J; Takahashi Y; Li M; Suzuki K; Xu R; Hishida T; Chang CJ; Esteban CR; Young J; Izpisua Belmonte JC
    Nat Commun; 2015 Mar; 6():6413. PubMed ID: 25752527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.
    Price AA; Grakoui A; Weiss DS
    Trends Microbiol; 2016 Apr; 24(4):294-306. PubMed ID: 26852268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas systems: new players in gene regulation and bacterial physiology.
    Sampson TR; Weiss DS
    Front Cell Infect Microbiol; 2014; 4():37. PubMed ID: 24772391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insights into the apo-structure of Cpf1 protein from Francisella novicida.
    Min K; Yoon H; Jo I; Ha NC; Jin KS; Kim JS; Lee HH
    Biochem Biophys Res Commun; 2018 Apr; 498(4):775-781. PubMed ID: 29526756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA. CRISPR goes retro.
    Sontheimer EJ; Marraffini LA
    Science; 2016 Feb; 351(6276):920-1. PubMed ID: 26917756
    [No Abstract]   [Full Text] [Related]  

  • 32. Microbial genetics: CRISPR memories of RNA.
    Waldron D
    Nat Rev Genet; 2016 Apr; 17(4):192-3. PubMed ID: 26948816
    [No Abstract]   [Full Text] [Related]  

  • 33. Degeneration of a CRISPR/Cas system and its regulatory target during the evolution of a pathogen.
    Sampson TR; Weiss DS
    RNA Biol; 2013 Oct; 10(10):1618-22. PubMed ID: 24100224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A CRISPR/Cas system mediates bacterial innate immune evasion and virulence.
    Sampson TR; Saroj SD; Llewellyn AC; Tzeng YL; Weiss DS
    Nature; 2013 May; 497(7448):254-7. PubMed ID: 23584588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional activation of the MICA gene with an engineered CRISPR-Cas9 system.
    Sekiba K; Yamagami M; Otsuka M; Suzuki T; Kishikawa T; Ishibashi R; Ohno M; Sato M; Koike K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):521-525. PubMed ID: 28322797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations.
    Ramakrishna S; Cho SW; Kim S; Song M; Gopalappa R; Kim JS; Kim H
    Nat Commun; 2014 Feb; 5():3378. PubMed ID: 24569644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expansion of the prime editing modality with Cas9 from Francisella novicida.
    Oh Y; Lee WJ; Hur JK; Song WJ; Lee Y; Kim H; Gwon LW; Kim YH; Park YH; Kim CH; Lim KS; Song BS; Huh JW; Kim SU; Jun BH; Jung C; Lee SH
    Genome Biol; 2022 Apr; 23(1):92. PubMed ID: 35410288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9: A New Tool for RNA Imaging in Live Cells.
    Rau K; Rentmeister A
    Chembiochem; 2016 Sep; 17(18):1682-4. PubMed ID: 27320049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases.
    Sung YH; Kim JM; Kim HT; Lee J; Jeon J; Jin Y; Choi JH; Ban YH; Ha SJ; Kim CH; Lee HW; Kim JS
    Genome Res; 2014 Jan; 24(1):125-31. PubMed ID: 24253447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion.
    Sampson TR; Napier BA; Schroeder MR; Louwen R; Zhao J; Chin CY; Ratner HK; Llewellyn AC; Jones CL; Laroui H; Merlin D; Zhou P; Endtz HP; Weiss DS
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11163-8. PubMed ID: 25024199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.